Safety, Tolerability, Immunogenicity and Immunological Mechanisms of TETRALITE, a Novel Seasonal Influenza Vaccine
Clinical trial NCT06294262 · UNKNOWN
Trial details
- NCT number
- NCT06294262
- Sponsor
- LiteVax BV
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-01-29
- Primary completion
- 2024-09-01
- Enrollment
- 84
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.